Fabry-betegség: vizsgálatok itt: Belgium
2 of 3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
- Where
- Leuven
- Életkor
- 2 év to 11 év
- People
- 8 worldwide
- Run by
- Amicus Therapeutics
See details and how to joinNCT06904261 - 3. fázisNot yet taking people in BelgiumAn Open-label Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of 12-month Treatment with Migalastat in Pediatric Subjects (aged 2 to < 12 years) with Fabry Disease and Amenable GLA Variants
- Where
- Leuven
- Életkor
- Up to 17 év
- People
- 3 worldwide
- Run by
- Amicus Therapeutics Inc.
See details and how to join2025-521244-38-00